
SmartQare
Provides world's first autonomous MDR CE class II marked medical 24/7 monitoring solution for remote patient care using IoT.
- B2B
- saas
- commission
- health
- pharmaceutical
- health platform
- medical devices
- deep tech
- iot internetofthings
- connected device
- big data
- artificial intelligence
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor | €0.0 | round |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €1.2m | Seed | |
Total Funding | 000k |
USD | 2022 | 2023 |
---|---|---|
Revenues | 0000 | 0000 |
% growth | - | 142 % |
EBITDA | 0000 | 0000 |
Profit | 0000 | 0000 |
EV | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x |
R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
SmartQare, established in 2017 in Eindhoven, the Netherlands, operates in the MedTech sector, developing remote patient monitoring solutions. The company was founded by Reinier Vrolijk, who has an extensive background as a senior online project manager, and Ronald Olie, who brings over 35 years of management and commercial experience. The leadership team includes CEO Walter van Kuijen, who previously managed home monitoring and telecare activities at Philips, bringing over 25 years of management experience in professional healthcare solutions.
The company's core business revolves around developing and providing continuous, remote patient monitoring solutions designed for use in hospitals, post-acute care, and home settings. SmartQare's business model focuses on providing medical-grade wearable devices and an integrated digital health platform to healthcare organizations. This approach aims to reduce healthcare costs and improve patient outcomes by enabling the early detection of health deterioration and streamlining workflows for medical professionals. In March 2022, the company successfully completed a €3 million funding round to support the medical validation and certification of its primary product.
SmartQare's main offering is viQtor, a multisensor wearable solution for 24-hour remote monitoring. Worn on the upper arm, viQtor continuously measures vital signs such as heart rate, oxygen saturation, respiration rate, and skin temperature, in addition to featuring activity tracking and fall detection. The data is transmitted in near real-time via low-power cellular networks (NB-IoT/LTE-M) to a secure cloud platform, eliminating the need for a separate gateway or mobile phone. Healthcare professionals can access this data through a dashboard or mobile app, allowing for timely interventions. Initially designed for at-home elderly care, its application expanded to in-hospital monitoring to help detect patient deterioration early. A key milestone for the company was the strategic partnership with Philips announced in early 2024, which involves integrating viQtor with Philips' clinical patient monitoring platforms to create a more unified monitoring ecosystem. As part of this collaboration, SmartQare acquired Philips' Healthdot business, combining it with the viQtor solution on a single digital platform.
Keywords: remote patient monitoring, MedTech, wearable biosensor, vital signs monitoring, continuous monitoring, digital health, healthcare technology, patient deterioration, fall detection, hospital-at-home, viQtor, Healthdot, in-hospital monitoring, remote diagnostics, telehealth, clinical workflow, care efficiency, patient safety, transmural care, medical device, EMR integration, healthcare data, predictive analytics, telecare solutions, chronic disease management, post-acute care, Netherlands